BioMarin Pharma (BMRN) Tops Q1 EPS by 39c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $64.06 +0.19%
Revenue Growth %: +31.4%
Financial Fact:
Interest expense: -9.98M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +31.4%
Financial Fact:
Interest expense: -9.98M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $0.60, $0.39 better than the analyst estimate of $0.21. Revenue for the quarter came in at $596.4 million versus the consensus estimate of $571.33 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
- Endava CFO placed on leave amid accounting probe
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
